Comparison of Pathologic Complete Response Rates and Oncologic Outcomes in Patients With Surgically Resectable Esophageal Cancer Treated With Neoadjuvant Chemoradiation to 50.4 Gy vs 41.4 Gy.
Saved in:
| Title: | Comparison of Pathologic Complete Response Rates and Oncologic Outcomes in Patients With Surgically Resectable Esophageal Cancer Treated With Neoadjuvant Chemoradiation to 50.4 Gy vs 41.4 Gy. |
|---|---|
| Authors: | Nehlsen AD; Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York City, USA., Lehrer EJ; Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York City, USA., Resende-Salgado L; Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York City, USA., Rosenzweig KE; Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York City, USA., Buckstein M; Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York City, USA. |
| Source: | Cureus [Cureus] 2021 Nov 03; Vol. 13 (11), pp. e19233. Date of Electronic Publication: 2021 Nov 03 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
